Drugs are an effective way to treat various diseases. Some diseases are so complicated that the effect of a single drug for such diseases is limited, which has led to the emergence of combination drug therapy. The use multiple drugs to treat these diseases can improve the drug efficacy, but it can also bring adverse effects. Thus, it is essential to determine drug-drug interactions (DDIs). Recently, deep learning algorithms have become popular to design DDI prediction models. However, most deep learning-based models need several types of drug properties, inducing the application problems for drugs without these properties. In this study, a new deep learning-based model was designed to predict DDIs. For wide applications, drugs were first represented by commonly used properties, referred to as fingerprint features. Then, these features were perfectly fused with the drug interaction network by a type of graph convolutional network method, GraphSAGE, yielding high-level drug features. The inner product was adopted to score the strength of drug pairs. The model was evaluated by 10-fold cross-validation, resulting in an AUROC of 0.9704 and AUPR of 0.9727. Such performance was better than the previous model which directly used drug fingerprint features and was competitive compared with some other previous models that used more drug properties. Furthermore, the ablation tests indicated the importance of the main parts of the model, and we analyzed the strengths and limitations of a model for drugs with different degrees in the network. This model identified some novel DDIs that may bring expected benefits, such as the combination of PEA and cannabinol that may produce better effects. DDIs that may cause unexpected side effects have also been discovered, such as the combined use of WIN 55,212-2 and cannabinol. These DDIs can provide novel insights for treating complex diseases or avoiding adverse drug events.
Citation: Bo Zhou, Bing Ran, Lei Chen. A GraphSAGE-based model with fingerprints only to predict drug-drug interactions[J]. Mathematical Biosciences and Engineering, 2024, 21(2): 2922-2942. doi: 10.3934/mbe.2024130
[1] | Khaled M. Saad, Manal Alqhtani . Numerical simulation of the fractal-fractional reaction diffusion equations with general nonlinear. AIMS Mathematics, 2021, 6(4): 3788-3804. doi: 10.3934/math.2021225 |
[2] | Abdon Atangana, Ali Akgül . Analysis of a derivative with two variable orders. AIMS Mathematics, 2022, 7(5): 7274-7293. doi: 10.3934/math.2022406 |
[3] | Abdon Atangana, Seda İğret Araz . Extension of Chaplygin's existence and uniqueness method for fractal-fractional nonlinear differential equations. AIMS Mathematics, 2024, 9(3): 5763-5793. doi: 10.3934/math.2024280 |
[4] | Manal Alqhtani, Khaled M. Saad . Numerical solutions of space-fractional diffusion equations via the exponential decay kernel. AIMS Mathematics, 2022, 7(4): 6535-6549. doi: 10.3934/math.2022364 |
[5] | Amir Ali, Abid Ullah Khan, Obaid Algahtani, Sayed Saifullah . Semi-analytical and numerical computation of fractal-fractional sine-Gordon equation with non-singular kernels. AIMS Mathematics, 2022, 7(8): 14975-14990. doi: 10.3934/math.2022820 |
[6] | Hasib Khan, Jehad Alzabut, Anwar Shah, Sina Etemad, Shahram Rezapour, Choonkil Park . A study on the fractal-fractional tobacco smoking model. AIMS Mathematics, 2022, 7(8): 13887-13909. doi: 10.3934/math.2022767 |
[7] | Rahat Zarin, Amir Khan, Pushpendra Kumar, Usa Wannasingha Humphries . Fractional-order dynamics of Chagas-HIV epidemic model with different fractional operators. AIMS Mathematics, 2022, 7(10): 18897-18924. doi: 10.3934/math.20221041 |
[8] | Muhammad Farman, Ali Akgül, Sameh Askar, Thongchai Botmart, Aqeel Ahmad, Hijaz Ahmad . Modeling and analysis of fractional order Zika model. AIMS Mathematics, 2022, 7(3): 3912-3938. doi: 10.3934/math.2022216 |
[9] | Muhammad Aslam, Muhammad Farman, Hijaz Ahmad, Tuan Nguyen Gia, Aqeel Ahmad, Sameh Askar . Fractal fractional derivative on chemistry kinetics hires problem. AIMS Mathematics, 2022, 7(1): 1155-1184. doi: 10.3934/math.2022068 |
[10] | Asif Khan, Tayyaba Akram, Arshad Khan, Shabir Ahmad, Kamsing Nonlaopon . Investigation of time fractional nonlinear KdV-Burgers equation under fractional operators with nonsingular kernels. AIMS Mathematics, 2023, 8(1): 1251-1268. doi: 10.3934/math.2023063 |
Drugs are an effective way to treat various diseases. Some diseases are so complicated that the effect of a single drug for such diseases is limited, which has led to the emergence of combination drug therapy. The use multiple drugs to treat these diseases can improve the drug efficacy, but it can also bring adverse effects. Thus, it is essential to determine drug-drug interactions (DDIs). Recently, deep learning algorithms have become popular to design DDI prediction models. However, most deep learning-based models need several types of drug properties, inducing the application problems for drugs without these properties. In this study, a new deep learning-based model was designed to predict DDIs. For wide applications, drugs were first represented by commonly used properties, referred to as fingerprint features. Then, these features were perfectly fused with the drug interaction network by a type of graph convolutional network method, GraphSAGE, yielding high-level drug features. The inner product was adopted to score the strength of drug pairs. The model was evaluated by 10-fold cross-validation, resulting in an AUROC of 0.9704 and AUPR of 0.9727. Such performance was better than the previous model which directly used drug fingerprint features and was competitive compared with some other previous models that used more drug properties. Furthermore, the ablation tests indicated the importance of the main parts of the model, and we analyzed the strengths and limitations of a model for drugs with different degrees in the network. This model identified some novel DDIs that may bring expected benefits, such as the combination of PEA and cannabinol that may produce better effects. DDIs that may cause unexpected side effects have also been discovered, such as the combined use of WIN 55,212-2 and cannabinol. These DDIs can provide novel insights for treating complex diseases or avoiding adverse drug events.
Fractional calculus has come out as one of the most applicable subjects of mathematics [1]. Its importance is evident from the fact that many real-world phenomena can be best interpreted and modeled using this theory. It is also a fact that many disciplines of engineering and science have been influenced by the tools and techniques of fractional calculus. Its emergence can easily be traced and linked with the famous correspondence between the two mathematicians, L'Hospital and Leibnitz, which was made on 30th September 1695. After that, many researchers tried to explore the concept of fractional calculus, which is based on the generalization of nth order derivatives or n-fold integration [2,3,4].
Recently, Khan and Khan [5] have discovered novel definitions of fractional integral and derivative operators. These operators enjoy interesting properties such as continuity, boundedeness, linearity etc. The integral operators, they presented, are stated as under:
Definition 1 ([5]). Let h∈Lθ[s,t](conformable integrable on [s,t]⊆[0,∞)). The left-sided and right-sided generalized conformable fractional integrals τθKνs+ and τθKνt− of order ν>0 with θ∈(0,1], τ∈R, θ+τ≠0 are defined by:
τθKνs+h(r)=1Γ(ν)r∫s(rτ+θ−wτ+θτ+θ)ν−1h(w)wτdθw,r>s, | (1.1) |
and
τθKνt−h(r)=1Γ(ν)t∫r(wτ+θ−rτ+θτ+θ)ν−1h(w)wτdθw,t>r, | (1.2) |
respectively, and τθK0s+h(r)=τθK0t−h(r)=h(r). Here Γ denotes the well-known Gamma function.
Here the integral t∫sdθw represents the conformable integration, defined as:
t∫sh(w)dθw=t∫sh(w)wθ−1dw. | (1.3) |
The operators defined in Definition 1 are in generalized form and contain few important operators in themselves. Here, only the left-sided operators are presented, the corresponding right-sided operators may be deduced in the similar way. Moreover, to understand the theory of conformable fractional calculus, one can see [5,6,7]. Also, the basic theory of fractional calculus can be found in the books [1,8,9] and for the latest research in this field one can see [3,4,10,11,12] and the references there in.
Remark 1. 1) For θ=1 in the Definition 1, the following Katugampula fractional integral operator is obtained [13]:
τ1Kνs+h(r)=1Γ(ν)r∫s(rτ+1−wτ+1τ+1)ν−1h(w)dw,r>s. | (1.4) |
2) For τ=0 in the Definition 1, the New Riemann Liouville type conformable fractional integral operator is obtained as given below:
0θKνs+h(r)=1Γ(ν)r∫s(rθ−wθθ)ν−1h(w)dθw,r>s. | (1.5) |
3) Using the definition of conformable integral given in (1.3) and L'Hospital rule, it is straightforward that when θ→0 in (1.5), we get the Hadamard fractional integral operator as follows:
00+Kνs+h(r)=1Γ(ν)r∫s(logrw)ν−1h(w)dww,r>s. | (1.6) |
4) For θ=1 in (1.5), the well-known Riemann-Liouville fractional integral operator is obtained as follows:
01Kνs+h(r)=1Γ(ν)r∫s(r−w)ν−1h(w)dw,r>s. | (1.7) |
5) For the case ν=1,τ=0 in Definition 1, we get the conformable fractional integrals. And when θ=ν=1, τ=0, we get the classical Riemann integrals.
This subsection is devoted to start with the definition of convex function, which plays a very important role in establishment of various kinds of inequalities [14]. This definition is given as follows [15]:
Definition 2. A function h:I⊆R→R is said to be convex on I if the inequality
h(ηs+(1−η)t)≤ηh(s)+(1−η)h(t) | (1.8) |
holds for all s,t∈I and 0≤η≤1. The function h is said to be concave on I if the inequality given in (1.8) holds in the reverse direction.
Associated with the Definition 2 of convex functions the following double inequality is well-known and it has been playing a key role in various fields of science and engineering [15].
Theorem 1. Let h:I⊆R→R be a convex function and s,t∈I with s<t. Then we have the following Hermite-Hadamard inequality:
h(s+t2)≤1t−st∫sh(τ)dτ≤h(s)+h(t)2. | (1.9) |
This inequality (1.9) appears in a reversed order if the function h is supposed to be concave. Also, the relation (1.9) provides upper and lower estimates for the integral mean of the convex function h. The inequality (1.9) has various versions (extensions or generalizations) corresponding to different integral operators [16,17,18,19,20,21,22,23,24,25] each version has further forms with respect to various kinds of convexities [26,27,28,29,30,31,32] or with respect to different bounds obtained for the absolute difference of the two leftmost or rightmost terms in the Hermite-Hadamard inequality.
By using the Riemann-Liouville fractional integral operators, Sirikaye et al. have proved the following Hermite-Hadamard inequality [33].
Theorem 2. ([33]). Let h:[s,t]→R be a function such that 0≤s<t and h∈L[s,t]. If h is convex on [s,t], then the following double inequality holds:
h(s+t2)≤Γ(ν+1)2(t−s)ν[01Kνs+h(t)+01Kνt−h(s)]≤h(s)+h(t)2. | (1.10) |
For more recent research related to generalized Hermite-Hadamard inequality one can see [34,35,36,37,38,39,40,41,42] and the references therein.
Motivated from the Riemann-Liouville version of Hermite-Hadamard inequality (given above in (1.10)), we prove the same inequality for newly introduced generalized conformable fractional operators. As a result we get a more generalized inequality, containing different versions of Hermite-Hadamard inequality in single form. We also prove an identity for generalized conformable fractional operators and establish a bound for the absolute difference of two rightmost terms in the newly obtained Hermite-Hadamard inequality. We point out some relations of our results with those of other results from the past. At the end we present conclusion, where directions for future research are also mentioned.
In the following theorem the well-known Hermite-Hadamard inequality for the newly defined integral operators is proved.
Theorem 3. Let ν>0 and τ∈R,θ∈(0,1] such that τ+θ>0. Let h:[s,t]⊆[0,∞)→R be a function such that h∈Lθ[s,t](conformal integrable on [s, t]). If h is also a convex function on [s,t], then the following Hermite-Hadamard inequality for generalized conformable fractional Integrals τθKνs+ and τθKνt− holds:
h(s+t2)≤(τ+θ)νΓ(ν+1)4(tτ+θ−sτ+θ)ν[τθKνs+H(t)+τθKνt−H(s)]≤h(s)+h(t)2, | (2.1) |
where H(x)=h(x)+˜h(x), ˜h(x)=h(s+t−x).
Proof. Let η∈[0,1]. Consider x,y∈[s,t], defined by x=ηs+(1−η)t,y=(1−η)s+ηt. Since h is a convex function on [s,t], we have
h(s+t2)=h(x+y2)≤h(x)+h(y)2=h(ηs+(1−η)t)+h((1−η)s+ηt)2. | (2.2) |
Multiplying both sides of (2.2) by
(t−s)(τ+θ)1−ν((1−η)s+ηt)τ+θ−1Γ(ν)[tτ+θ−((1−η)s+ηt)τ+θ]1−ν, |
and integrating with respect to η, we get
(t−s)(τ+θ)1−νΓ(ν)h(s+t2)1∫0((1−η)s+ηt)τ+θ−1[tτ+θ−((1−η)s+ηt)τ+θ]1−νdη≤(t−s)(τ+θ)1−νΓ(ν)12{1∫0((1−η)s+ηt)τ+θ−1[tτ+θ−((1−η)s+ηt)τ+θ]1−νh(ηs+(1−η)t)dη+1∫0(1−η)s+ηt)τ+θ−1[tτ+θ−((1−η)s+ηt)τ+θ]1−νh((1−η)s+ηt)dη}. | (2.3) |
Note that we have
1∫0((1−η)s+ηt)τ+θ−1[tτ+θ−((1−η)s+ηt)τ+θ]1−νdη=1ν(τ+θ)(t−s)(tτ+θ−sτ+θ)ν. |
Also, by using the identity ˜h((1−η)s+ηt)=h(ηs+(1−η)t), and making substitution (1−η)s+ηt=w, we get
(t−s)(τ+θ)1−νΓ(ν)1∫0((1−η)s+ηt)τ+θ−1[tτ+θ−((1−η)s+ηt)τ+θ]1−νh(ηs+(1−η)t)dη=(τ+θ)1−νΓ(ν)t∫swτ+θ−1[tτ+θ−wτ+θ]1−ν˜h(w)dw=(τ+θ)1−νΓ(ν)t∫swτ[tτ+θ−wτ+θ]1−ν˜h(w)dθw=τθKνs+˜h(t). | (2.4) |
Similarly
(t−s)(τ+θ)1−νΓ(ν)1∫0((1−η)s+ηt)τ+θ−1[tτ+θ−((1−η)s+ηt)τ+θ]1−νh(ηt+(1−η)s)dη=τθKνs+h(t). | (2.5) |
By substituting these values in (2.3), we get
(tτ+θ−sτ+θ)νΓ(ν+1)(τ+θ)νh(s+t2)≤τθKνs+H(t)2. | (2.6) |
Again, by multiplying both sides of (2.2) by
(t−s)(τ+θ)1−ν((1−η)s+ηt)τ+θ−1Γ(ν)[((1−η)s+ηt)τ+θ−sτ+θ]1−ν, |
and then integrating with respect to η and by using the same techniques used above, we can obtain:
(tτ+θ−sτ+θ)νΓ(ν+1)(τ+θ)νh(s+t2)≤τθKνt−H(s)2. | (2.7) |
Adding (2.7) and (2.6), we get:
h(s+t2)≤Γ(ν+1)(τ+θ)ν4(tτ+θ−sτ+θ)ν[τθKνs+H(t)+τθKνt−H(s)]. | (2.8) |
Hence the left-hand side of the inequality (2.1) is established.
Also since h is convex, we have:
h(ηs+(1−η)t)+h((1−η)s+ηt)≤h(s)+h(t). | (2.9) |
Multiplying both sides
(t−s)(τ+θ)1−ν((1−η)s+ηt)τ+θ−1Γ(ν)[tτ+θ−((1−η)s+ηt)τ+θ]1−ν, |
and integrating with respect to η we get
(t−s)(τ+θ)1−νΓ(ν)1∫0((1−η)s+ηt)τ+θ−1[tτ+θ−((1−η)s+ηt)τ+θ]1−νh(ηs+(1−η)t)dη+(t−s)(τ+θ)1−νΓ(ν)1∫0((1−η)s+ηt)τ+θ−1[tτ+θ−((1−η)s+ηt)τ+θ]1−νh(ηt+(1−η)s)dη≤(t−s)(τ+θ)1−νΓ(ν)[h(s)+h(t)]1∫0(1−η)s+ηt)τ+θ−1[tτ+θ−((1−η)s+ηt)τ+θ]1−νdη, | (2.10) |
that is,
τθKνs+H(t)≤(tτ+θ−sτ+θ)νΓ(ν+1)(τ+θ)ν[h(s)+h(t)]. | (2.11) |
Similarly multiplying both sides of (2.9) by
(t−s)(τ+θ)1−ν((1−η)s+ηt)τ+θ−1Γ(ν)[((1−η)s+ηt)τ+θ−sτ+θ]1−ν, |
and integrating with respect to η, we can obtain
τθKνt−H(s)≤(tτ+θ−sτ+θ)νΓ(ν+1)(τ+θ)ν[h(s)+h(t)]. | (2.12) |
Adding the inequalities (2.11) and (2.12), we get:
Γ(ν+1)(τ+θ)ν4(tτ+θ−sτ+θ)ν[τθKνt−H(s)+τθKνs+H(t)]≤h(s)+h(t)2. | (2.13) |
Combining (2.8) and (2.13), we get the required result.
The inequality in (2.1) is in compact form containing few inequalities for different integrals in it. The following remark tells us about that fact.
Remark 2. 1) For θ=1 in (2.1), we get Hermite-Hadamard inequality for Katugampola fractional integral operators, as follows [38]:
h(s+t2)≤(τ+1)νΓ(ν+1)4(tτ+1−sτ+1)ν[τ1Kνs+H(t)+τ1Kνt−H(s)]≤h(s)+h(t)2, | (2.14) |
where H(x)=h(x)+˜h(x), ˜h(x)=h(s+t−x).
2) For τ=0 in (2.1), we get Hermite-Hadamard inequality for newly obtained Riemann Liouville type conformable fractional integral operators, as follows:
h(s+t2)≤θνΓ(ν+1)4(tθ−sθ)ν[0θKνs+H(t)+0θKνt−H(s)]≤h(s)+h(t)2, | (2.15) |
where H(x)=h(x)+˜h(x), ˜h(x)=h(s+t−x).
3) For τ+θ→0, in (2.1), applying L'Hospital rule and the relation (1.3), we get Hermite-Hadamard inequality for Hadamard fractional integral operators, as follows:
h(s+t2)≤Γ(ν+1)2(lnts)ν[00+Kνs+h(t)+00+Kνt−h(s)]≤h(s)+h(t)2. | (2.16) |
4) For τ+θ=1 in (2.1), the Hermite-Hadamard inequality is obtained for Riemann-Liouville fractional integrals [33]:
h(s+t2)≤Γ(ν+1)2(t−s)ν[01Kνs+h(t)+01Kνt−h(s)]≤h(s)+h(t)2. | (2.17) |
5) For the case ν=1,τ=0 in (2.1), the Hermite-Hadamard inequality is obtained for the conformable fractional integrals as follows:
h(s+t2)≤θ2(tθ−sθ)t∫sH(w)dθw≤h(s)+h(t)2. | (2.18) |
6) When θ=ν=1, τ=0 the Hermite-Hadamard inequality is obtained for classical Riemann integrals [15]:
h(s+t2)≤1t−st∫sh(w)dw≤h(s)+h(t)2. | (2.19) |
To bound the difference of two rightmost terms in the main inequality (2.1), we need to establish the following Lemma.
Lemma 1. Let τ+θ>0 and ν>0. If h∈Lθ[s,t], then
h(s)+h(t)2−(τ+θ)νΓ(ν+1)4(tτ+θ−sτ+θ)ν[τθKνs+H(t)+τθKνt−H(s)]=t−s4(tτ+θ−sτ+θ)ν1∫0Δντ+θ(η)h′(ηs+(1−η)t)dη, | (2.20) |
where
Δντ+θ(η)=[(ηs+(1−η)t)τ+θ−sτ+θ]ν−[(ηt+(1−η)s)τ+θ−sτ+θ]ν+[tτ+θ−((1−η)s+ηt)τ+θ]ν−[tτ+θ−((1−η)t+ηs)τ+θ]ν. |
Proof. With the help of integration by parts, we have
τθKνs+H(t)=(tτ+θ−sτ+θ)ν(τ+θ)νΓ(ν+1)H(s)+(t−s)ν(τ+θ)νΓ(ν+1)1∫0[tτ+θ−((1−η)s+ηt)τ+θ]νH′(ηt+(1−η)s)dη. | (2.21) |
Similarly, we have
τθKνt−H(s)=(tτ+θ−sτ+θ)ν(τ+θ)νΓ(ν+1)H(t)−(t−s)ν(τ+θ)νΓ(ν+1)1∫0[((1−η)s+ηt)τ+θ−sτ+θ]νH′(ηt+(1−η)s)dη. | (2.22) |
Using (2.21) and (2.22) we have
4(tτ+θ−sτ+θ)νt−s(h(s)+h(t)2−(τ+θ)νΓ(ν+1)4(tτ+θ−sτ+θ)ν[τθKνt−H(s)+τθKνs+H(t)])=1∫0([((1−η)s+ηt)τ+θ−sτ+θ]ν−[(tτ+θ−((1−η)s+ηt)τ+θ]ν)H′(ηt+(1−η)s)dη. | (2.23) |
Also, we have
H′(ηt+(1−η)s)=h′(ηt+(1−η)s)−h′(ηs+(1−η)t),η∈[0,1]. | (2.24) |
And
1∫0[((1−η)s+ηt)τ+θ−sτ+θ]νH′(ηt+(1−η)s)dη=1∫0[((1−η)t+ηs)τ+θ−sτ+θ]νh′(ηs+(1−η)t)dη−1∫0[((1−η)s+ηt)τ+θ−sτ+θ]νh′(ηs+(1−η)t)dη. | (2.25) |
Also, we have
1∫0[tτ+θ−((1−η)s+ηt)τ+θ]νH′(ηt+(1−η)s)dη=1∫0[tτ+θ−((1−η)t+ηs)τ+θ]νh′(ηs+(1−η)t)dη−1∫0[tτ+θ−((1−η)s+ηt)τ+θ]νh′(ηs+(1−η)t)dη. | (2.26) |
Using (2.23), (2.25) and (2.26) we get the required result.
Remark 3. When τ+θ=1 in Lemma 1, we get the Lemma 2 in [33].
Definition 3. For ν>0, we define the operators
Ων1(x,y,τ+θ)=s+t2∫s|x−w||yτ+θ−wτ+θ|νdw−t∫s+t2|x−w||yτ+θ−wτ+θ|νdw, | (2.27) |
and
Ων2(x,y,τ+θ)=s+t2∫s|x−w||wτ+θ−yτ+θ|νdw−t∫s+t2|x−w||wτ+θ−yτ+θ|νdw, | (2.28) |
where x,y∈[s,t]⊆[0,∞) and τ+θ>0.
Theorem 4. Let h be a conformable integrable function over [s,t] such that |h′| is convex function. Then for ν>0 and τ+θ>0 we have:
|h(s)+h(t)2−(τ+θ)νΓ(ν+1)4(tτ+θ−sτ+θ)ν[τθKνs+H(t)+τθKνt−H(s)]|≤Kντ+θ(s,t)4(t−s)(tτ+θ−sτ+θ)ν(|h′(s)|+|h′(t)|), | (2.29) |
where Kντ+θ(s,t)=Ων1(t,t,τ+θ)+Ων2(s,s,τ+θ)−Ων2(t,s,τ+θ)−Ων1(s,t,τ+θ).
Proof. Using Lemma 1 and convexity of |h′|, we have:
|h(s)+h(t)2−(τ+θ)νΓ(ν+1)4(tτ+θ−sτ+θ)ν[τθKνs+H(t)+τθKνt−H(s)]|≤t−s4(tτ+θ−sτ+θ)ν1∫0|Δντ+θ(η)||h′(ηs+(1−η)t)|dη≤t−s4(tτ+θ−sτ+θ)ν(|h′(s)|1∫0η|Δντ+θ(η)|dη+|h′(t)|1∫0(1−η)|Δντ+θ(η)|dη). | (2.30) |
Here 1∫0η|Δντ+θ(η)|dη=1(t−s)2t∫s|ψ(u)|(t−u)du,
and ψ(u)=(uτ+θ−sτ+θ)ν−((t+s−u)τ+θ−sτ+θ)ν+(tτ+θ−(s+t−u)τ+θ)ν−(tτ+θ−uτ+θ)ν.
We observe that ψ is a nondecreasing function on [s,t]. Moreover, we have:
ψ(s)=−2(tτ+θ−sτ+θ)ν<0, |
and also ψ(s+t2)=0. As a consequence, we have
{ψ(u)≤0,if s≤u≤s+t2,ψ(u)>0,if s+t2<u≤t. |
Thus we get
1∫0η|Δντ+θ(η)|dη=1(t−s)2t∫s|ψ(u)|(t−u)du=1(t−s)2[−s+t2∫sψ(u)(t−u)du+t∫s+t2ψ(u)(t−u)du]=1(t−s)2[K1+K2+K3+K4], | (2.31) |
where
K1=−s+t2∫s(t−u)(uτ+θ−sτ+θ)νdu+t∫s+t2(t−u)(uτ+θ−sτ+θ)νdu, | (2.32) |
K2=s+t2∫s(t−u)((t+s−u)τ+θ−sτ+θ)νdu−t∫s+t2(t−u)((t+s−u)τ+θ−sτ+θ)νdu, | (2.33) |
K3=−s+t2∫s(t−u)(tτ+θ−(s+t−u)τ+θ)νdu+t∫s+t2(t−u)(tτ+θ−(s+t−u)τ+θ)νdu, | (2.34) |
and
K4=s+t2∫s(t−u)(tτ+θ−uτ+θ)νdu−t∫s+t2(t−u)(tτ+θ−uτ+θ)νdu. | (2.35) |
We can see here that K1=−Ων2(t,s,τ+θ), K4=Ων1(t,t,τ+θ).
Also, by using of change of the variables v=s+t−u, we get
K2=Ων2(s,s,τ+θ),K3=−Ων1(s,t,τ+θ). | (2.36) |
By substituting these values in (2.31), we get
1∫0ηΔντ+θ(η)dη=−Ων2(t,s,τ+θ)+Ων1(t,t,τ+θ)+Ων2(s,s,τ+θ)−Ων1(s,t,τ+θ)(t−s)2. | (2.37) |
Similarly, we can find
1∫0(1−η)Δντ+θ(η)dη=Ων2(s,s,τ+θ)−Ων2(t,s,τ+θ)+Ων1(t,t,τ+θ)−Ων1(s,t,τ+θ)(t−s)2. | (2.38) |
Finally, by using (2.30), (2.37) and (2.38) we get the required result.
Remark 4. when τ+θ=1 in (2.29), we obtain
|h(s)+h(t)2−Γ(ν+1)2(t−s)ν[01Kνt−h(s)+01Kνs+h(t)]|≤(t−s)2(ν+1)(1−12ν)[h′(s)+h′(t)], |
which is Theorem 3 in [33].
A generalized version of Hermite-Hadamard inequality via newly introduced GC fractional operators has been acquired successfully. This result combines several versions (new and old) of the Hermite-Hadamard inequality into a single form, each one has been discussed by fixing parameters in the newly established version of the Hermite-Hadamard inequality. Moreover, an identity containing the GC fractional integral operators has been proved. By using this identity, a bound for the absolute of the difference between the two rightmost terms in the newly established Hermite-Hadamard inequality has been presented. Also, some relations of our results with those of already existing results have been pointed out. Since this is a fact that there exist more than one definitions for fractional derivatives [2] which makes it difficult to choose a convenient operator for solving a given problem. Thus, in the present paper, the GC fractional operators (containing various previously defined fractional operators into a single form) have been used in order to overcome the problem of choosing a suitable fractional operator and to provide a unique platform for researchers working with different operators in this field. Also, by making use of GC fractional operators one can follow the research work which has been performed for the two versions (1.9) and (1.10) of Hermite-Hadamard inequality.
This work was supported by the Natural Science Foundation of China (Grant Nos. 61673169, 11301127, 11701176, 11626101, 11601485).
The authors declare that there are no conflicts of interest regarding the publication of this paper.
[1] |
G. Lee, C. Park, J. Ahn, Novel deep learning model for more accurate prediction of drug-drug interaction effects, BMC Bioinf., 20 (2019), 415. https://doi.org/10.1186/s12859-019-3013-0 doi: 10.1186/s12859-019-3013-0
![]() |
[2] |
Y. Deng, X. Xu, Y. Qiu, J. Xia, W. Zhang, S. Liu, A multimodal deep learning framework for predicting drug-drug interaction events, Bioinformatics, 36 (2020), 4316–4322. https://doi.org/10.1093/bioinformatics/btaa501 doi: 10.1093/bioinformatics/btaa501
![]() |
[3] |
L. Chen, C. Chu, Y. H. Zhang, M. Zheng, L. Zhu, X. Kong, et al., Identification of drug-drug interactions using chemical interactions, Curr. Bioinf., 12 (2017), 526–534. https://doi.org/10.2174/1574893611666160618094219 doi: 10.2174/1574893611666160618094219
![]() |
[4] |
F. Cheng, Z. Zhao, Machine learning-based prediction of drug–drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties, J. Am. Med. Inf. Assoc., 21 (2014), e278–e286. https://doi.org/10.1136/amiajnl-2013-002512 doi: 10.1136/amiajnl-2013-002512
![]() |
[5] |
B. Ran, L. Chen, M. Li, Y. Han, Q. Dai, Drug-drug interactions prediction using fingerprint only, Comput. Math. Methods Med., 2022 (2022), 7818480. https://doi.org/10.1155/2022/7818480 doi: 10.1155/2022/7818480
![]() |
[6] |
C. Yan, G. Duan, Y. Pan, F. X. Wu, J. Wang, DDIGIP: Predicting drug-drug interactions based on Gaussian interaction profile kernels, BMC Bioinf., 20 (2019), 538. https://doi.org/10.1186/s12859-019-3093-x doi: 10.1186/s12859-019-3093-x
![]() |
[7] |
N. Rohani, C. Eslahchi, Drug-drug interaction predicting by neural network using integrated similarity, Sci. Rep., 9 (2019), 13645. https://doi.org/10.1038/s41598-019-50121-3 doi: 10.1038/s41598-019-50121-3
![]() |
[8] |
A. M. Roy, J. Bhaduri, DenseSPH-YOLOv5: An automated damage detection model based on DenseNet and Swin-Transformer prediction head-enabled YOLOv5 with attention mechanism, Adv. Eng. Inf., 56 (2023), 102007. https://doi.org/10.1016/j.aei.2023.102007 doi: 10.1016/j.aei.2023.102007
![]() |
[9] |
S. Jamil, A. M. Roy, An efficient and robust Phonocardiography (PCG)-based Valvular Heart Diseases (VHD) detection framework using Vision Transformer (ViT), Comput. Biol. Med., 158 (2023), 106734. https://doi.org/10.1016/j.compbiomed.2023.106734 doi: 10.1016/j.compbiomed.2023.106734
![]() |
[10] |
A. M. Roy, J. Bhaduri, T. Kumar, K. Raj, WilDect-YOLO: An efficient and robust computer vision-based accurate object localization model for automated endangered wildlife detection, Ecol. Inf., 75 (2023), 101919. https://doi.org/10.1016/j.ecoinf.2022.101919 doi: 10.1016/j.ecoinf.2022.101919
![]() |
[11] |
B. Jiang, S. Chen, B. Wang, B. Luo, MGLNN: Semi-supervised learning via multiple graph cooperative learning neural networks, Neural Networks, 153 (2022), 204–214. https://doi.org/10.1016/j.neunet.2022.05.024 doi: 10.1016/j.neunet.2022.05.024
![]() |
[12] |
C. He, Y. Liu, H. Li, H. Zhang, Y. Mao, X. Qin, et al., Multi-type feature fusion based on graph neural network for drug-drug interaction prediction, BMC Bioinf., 23 (2022), 224. https://doi.org/10.1186/s12859-022-04763-2 doi: 10.1186/s12859-022-04763-2
![]() |
[13] |
X. Y. Yan, P. W. Yin, X. M. Wu, J. X. Han, Prediction of the drug-drug interaction types with the unified embedding features from drug similarity networks, Front. Pharmacol., 12 (2021), 794205. https://doi.org/10.3389/fphar.2021.794205 doi: 10.3389/fphar.2021.794205
![]() |
[14] |
S. Lin, Y. Wang, L. Zhang, Y. Chu, Y. Liu, Y. Fang, et al., MDF-SA-DDI: Predicting drug-drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanism, Briefings Bioinf., 23 (2022), bbab421. https://doi.org/10.1093/bib/bbab421 doi: 10.1093/bib/bbab421
![]() |
[15] |
Y. H. Feng, S. W. Zhang, J. Y. Shi, DPDDI: A deep predictor for drug-drug interactions, BMC Bioinf., 21 (2020), 419. https://doi.org/10.1186/s12859-020-03724-x doi: 10.1186/s12859-020-03724-x
![]() |
[16] |
S. Liu, Y. Zhang, Y. Cui, Y. Qiu, Y. Deng, Z. Zhang, et al., Enhancing drug-drug interaction prediction using deep attention neural networks, IEEE/ACM Trans. Comput. Biol. Bioinf., 20 (2023), 976–985. https://doi.org/10.1109/TCBB.2022.3172421 doi: 10.1109/TCBB.2022.3172421
![]() |
[17] |
D. S. Wishart, C. Knox, A. C. Guo, D. Cheng, S. Shrivastava, D. Tzur, et al., DrugBank: A knowledgebase for drugs, drug actions and drug targets, Nucleic Acids Res., 36 (2008), D901–D906. https://doi.org/10.1093/nar/gkm958 doi: 10.1093/nar/gkm958
![]() |
[18] |
D. S. Wishart, C. Knox, A. C. Guo, S. Shrivastava, M. Hassanali, P. Stothard, et al., DrugBank: A comprehensive resource for in silico drug discovery and exploration, Nucleic Acids Res., 34 (2006), D668–D672. https://doi.org/10.1093/nar/gkj067 doi: 10.1093/nar/gkj067
![]() |
[19] | W. Hamilton, Z. Ying, J. Leskovec, Inductive representation learning on large graphs, in NIPS'17: Proceedings of the 31st International Conference on Neural Information Processing Systems, (2017), 1024–1034. |
[20] |
X. Pan, L. Chen, I. Liu, Z. Niu, T. Huang, Y. D. Cai, Identifying protein subcellular locations with embeddings-based node2loc, IEEE/ACM Trans. Comput. Biol. Bioinf., 19 (2022), 666–675. https://doi.org/10.1109/TCBB.2021.3080386 doi: 10.1109/TCBB.2021.3080386
![]() |
[21] |
J. P. Zhou, L. Chen, Z. H. Guo, iATC-NRAKEL: An efficient multi-label classifier for recognizing anatomical therapeutic chemical classes of drugs, Bioinformatics, 36 (2020), 1391–1396. https://doi.org/10.1093/bioinformatics/btz757 doi: 10.1093/bioinformatics/btz757
![]() |
[22] |
C. Wu, L. Chen, A model with deep analysis on a large drug network for drug classification, Math. Biosci. Eng., 20 (2023), 383–401. https://doi.org/10.3934/mbe.2023018 doi: 10.3934/mbe.2023018
![]() |
[23] |
L. Chen, K. Chen, B. Zhou, Inferring drug-disease associations by a deep analysis on drug and disease networks, Math. Biosci. Eng., 20 (2023), 14136–14157. https://doi.org/10.3934/mbe.2023632 doi: 10.3934/mbe.2023632
![]() |
[24] |
L. Chen, J. Xu, Y. Zhou, PDATC-NCPMKL: Predicting drug's Anatomical Therapeutic Chemical (ATC) codes based on network consistency projection and multiple kernel learning, Comput. Biol. Med., 169 (2024), 107862. https://doi.org/10.1016/j.compbiomed.2023.107862 doi: 10.1016/j.compbiomed.2023.107862
![]() |
[25] |
M. A. Alsmirat, F. Al-Alem, M. Al-Ayyoub, Y. Jararweh, B. Gupta, Impact of digital fingerprint image quality on the fingerprint recognition accuracy, Multimedia Tools Appl., 78 (2019), 3649–3688. https://doi.org/10.1007/s11042-017-5537-5 doi: 10.1007/s11042-017-5537-5
![]() |
[26] |
N. Nedjah, R. S. Wyant, L. M. Mourelle, B. B. Gupta, Efficient fingerprint matching on smart cards for high security and privacy in smart systems, Inf. Sci., 479 (2019), 622–639. https://doi.org/10.1016/j.ins.2017.12.038 doi: 10.1016/j.ins.2017.12.038
![]() |
[27] |
B. D. Christie, B. A. Leland, J. G. Nourse, Structure searching in chemical databases by direct lookup methods, J. Chem. Inf. Comput. Sci., 33 (1993), 545–547. https://doi.org/10.1021/ci00014a004 doi: 10.1021/ci00014a004
![]() |
[28] |
D. Rogers, M. Hahn, Extended-connectivity fingerprints, J. Chem. Inf. Model., 50 (2010), 742–754. https://doi.org/10.1021/ci100050t doi: 10.1021/ci100050t
![]() |
[29] | T. N. Kipf, M. Welling, Semi-supervised classification with graph convolutional networks, arXiv preprint, (2016), arXiv: 160902907. https://doi.org/10.48550/arXiv.1609.02907 |
[30] |
X. Wang, M. Liu, Y. Zhang, S. He, C. Qin, Y. Li, et al., Deep fusion learning facilitates anatomical therapeutic chemical recognition in drug repurposing and discovery, Briefings Bioinf., 22 (2021), bbab289. https://doi.org/10.1093/bib/bbab289 doi: 10.1093/bib/bbab289
![]() |
[31] |
H. Zhao, Y. Li, J. Wang, A convolutional neural network and graph convolutional network-based method for predicting the classification of anatomical therapeutic chemicals, Bioinformatics, 37 (2021), 2841–2847. https://doi.org/10.1093/bioinformatics/btab204 doi: 10.1093/bioinformatics/btab204
![]() |
[32] |
X. Y. Pan, H. B. Shen, Inferring disease-associated microRNAs using semi-supervised multi-label graph convolutional networks, Iscience, 20 (2019), 265–277. https://doi.org/10.1016/j.isci.2019.09.013 doi: 10.1016/j.isci.2019.09.013
![]() |
[33] |
M. Tsubaki, K. Tomii, J. Sese, Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences, Bioinformatics, 35 (2019), 309–318. https://doi.org/10.1093/bioinformatics/bty535 doi: 10.1093/bioinformatics/bty535
![]() |
[34] | D. P. Kingma, J. Ba, Adam: A method for stochastic optimization, in the 3rd International Conference for Learning Representations, Louisiana, USA, (2019). |
[35] | R. Kohavi, A study of cross-validation and bootstrap for accuracy estimation and model selection, in IJCAI'95: Proceedings of the 14th International Joint Conference on Artificial Intelligence-Volume 2, (1995), 1137–1145. |
[36] | D. Powers, Evaluation: From precision, recall and F-measure to ROC, informedness, markedness & correlation, J. Mach. Learn. Technol., 2 (2011), 37–63. |
[37] |
F. Huang, Q. Ma, J. Ren, J. Li, F. Wang, T. Huang, et al., Identification of smoking associated transcriptome aberration in blood with machine learning methods, BioMed Res. Int., 2023 (2023), 5333361. https://doi.org/10.1155/2023/5333361 doi: 10.1155/2023/5333361
![]() |
[38] |
H. Wang, L. Chen, PMPTCE-HNEA: Predicting metabolic pathway types of chemicals and enzymes with a heterogeneous network embedding algorithm, Curr. Bioinf., 18 (2023), 748–759. https://doi.org/10.2174/1574893618666230224121633 doi: 10.2174/1574893618666230224121633
![]() |
[39] |
J. Ren, Y. Zhang, W. Guo, K. Feng, Y. Yuang, T. Huang, et al., Identification of genes associated with the impairment of olfactory and gustatory functions in COVID-19 via machine-learning methods, Life, 13 (2023), 798. https://doi.org/10.3390/life13030798 doi: 10.3390/life13030798
![]() |
[40] |
L. Chen, X. Zhao, PCDA-HNMP: Predicting circRNA-disease association using heterogeneous network and meta-path, Math. Biosci. Eng., 20 (2023), 20553–20575. https://doi.org/10.3934/mbe.2023909 doi: 10.3934/mbe.2023909
![]() |
[41] |
L. Chen, Y. Chen, RMTLysPTM: Recognizing multiple types of lysine PTM sites by deep analysis on sequences, Briefings Bioinf., 25 (2024), bbad450. https://doi.org/10.1093/bib/bbad450 doi: 10.1093/bib/bbad450
![]() |
[42] |
L. Chen, R. Qu, X. Liu, Improved multi-label classifiers for predicting protein subcellular localization, Math. Biosci. Eng., 21 (2024), 214–236. https://doi.org/10.3934/mbe.2024010 doi: 10.3934/mbe.2024010
![]() |
[43] |
B. Matthews, Comparison of the predicted and observed secondary structure of T4 phage lysozyme, Biochim. Biophys. Acta Protein Struct., 405 (1975), 442–451. https://doi.org/10.1016/0005-2795(75)90109-9 doi: 10.1016/0005-2795(75)90109-9
![]() |
[44] |
K. B. Walsh, A. E. McKinney, A. E. Holmes, Minor cannabinoids: Biosynthesis, molecular pharmacology and potential therapeutic uses, Front. Pharmacol., 12 (2021), 777804. https://doi.org/10.3389/fphar.2021.777804 doi: 10.3389/fphar.2021.777804
![]() |
[45] |
B. Rezende, A. K. N. Alencar, G. F. de Bem, F. L. Fontes-Dantas, G. C. Montes, Endocannabinoid system: Chemical characteristics and biological activity, Pharmaceuticals (Basel), 16 (2023), 148. https://doi.org/10.3390/ph16020148 doi: 10.3390/ph16020148
![]() |
[46] |
P. B. Sampson, Phytocannabinoid pharmacology: Medicinal properties of cannabis sativa constituents aside from the "Big Two", J. Nat. Prod., 84 (2021), 142–160. https://doi.org/10.1021/acs.jnatprod.0c00965 doi: 10.1021/acs.jnatprod.0c00965
![]() |
[47] | InMed pharmaceuticals announces commencement of phase 2 clinical trial investigating cannabinol (CBN), a rare cannabinoid, in the treatment of epidermolysis bullosa, InMed Pharmaceuticals Inc., 2021. |
[48] |
P. Clayton, M. Hill, N. Bogoda, S. Subah, R. Venkatesh, Palmitoylethanolamide: A natural compound for health management, Int. J. Mol. Sci., 22 (2021), 5305. https://doi.org/10.3390/ijms22105305 doi: 10.3390/ijms22105305
![]() |
[49] |
P. Clayton, S. Subah, R. Venkatesh, M. Hill, N. Bogoda, Palmitoylethanolamide: A potential alternative to cannabidiol, J. Diet. Suppl., 20 (2023), 505–530. https://doi.org/10.1080/19390211.2021.2005733 doi: 10.1080/19390211.2021.2005733
![]() |
[50] |
E. B. Russo, Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects, Br. J. Pharmacol., 163 (2011), 1344–1364. https://doi.org/10.1111/j.1476-5381.2011.01238.x doi: 10.1111/j.1476-5381.2011.01238.x
![]() |
[51] |
W. S. Ho, D. A. Barrett, M. D. Randall, 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors, Br. J. Pharmacol., 155 (2008), 837–846. https://doi.org/10.1038/bjp.2008.324 doi: 10.1038/bjp.2008.324
![]() |
[52] |
A. Mabou Tagne, Y. Fotio, L. Lin, E. Squire, F. Ahmed, T. I. Rashid, et al., Palmitoylethanolamide and hemp oil extract exert synergistic anti-nociceptive effects in mouse models of acute and chronic pain, Pharmacol. Res., 167 (2021), 105545. https://doi.org/10.1016/j.phrs.2021.105545 doi: 10.1016/j.phrs.2021.105545
![]() |
[53] |
M. H. Bloch, A. Landeros-Weisenberger, J. A. Johnson, J. F. Leckman, A phase-2 pilot study of a therapeutic combination of Delta (9)-Tetrahydracannabinol and Palmitoylethanolamide for adults with Tourette's syndrome, J. Neuropsychiatry Clin. Neurosci., 33 (2021), 328–336. https://doi.org/10.1176/appi.neuropsych.19080178 doi: 10.1176/appi.neuropsych.19080178
![]() |
[54] |
J. Lott, E. M. Jutkiewicz, M. A. Puthenveedu, The synthetic cannabinoid WIN55,212-2 can disrupt the Golgi apparatus independent of cannabinoid receptor-1, Mol. Pharmacol., 101 (2022), 371–380. https://doi.org/10.1124/molpharm.121.000377 doi: 10.1124/molpharm.121.000377
![]() |
[55] | J. E. Kuster, J. I. Stevenson, S. J. Ward, T. E. D'Ambra, D. A. Haycock, Aminoalkylindole binding in rat cerebellum: Selective displacement by natural and synthetic cannabinoids, J. Pharmacol. Exp. Ther., 264 (1993), 1352–1363. |
[56] | L. Ferraro, M. C. Tomasini, G. L. Gessa, B. W. Bebe, S. Tanganelli, T. Antonelli, The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: An in vivo and in vitro study, Cereb. Cortex, 11 (2001), 728–733. |
[57] |
S. E. O'Sullivan, An update on PPAR activation by cannabinoids, Br. J. Pharmacol., 173 (2016), 1899–1910. https://doi.org/10.1111/bph.13497 doi: 10.1111/bph.13497
![]() |
[58] |
J. A. Fields, M. K. Swinton, P. Montilla-Perez, E. Ricciardelli, F. Telese, The cannabinoid receptor agonist, WIN-55212-2, suppresses the activation of proinflammatory genes induced by interleukin 1 beta in human astrocytes, Cannabis Cannabinoid Res., 7 (2022), 78–92. https://doi.org/10.1089/can.2020.0128 doi: 10.1089/can.2020.0128
![]() |
[59] |
G. T. Carter, S. P. Javaher, M. H. Nguyen, S. Garret, B. H. Carlini, Re-branding cannabis: The next generation of chronic pain medicine, Pain Manage., 5 (2015), 13–21. https://doi.org/10.2217/pmt.14.49 doi: 10.2217/pmt.14.49
![]() |
[60] |
J. P. Szaflarski, E. M. Bebin, Cannabis, cannabidiol, and epilepsy--from receptors to clinical response, Epilepsy Behav., 41 (2014), 277–282. https://doi.org/10.1016/j.yebeh.2014.08.135 doi: 10.1016/j.yebeh.2014.08.135
![]() |
[61] |
J. K. Fitzpatrick, E. J. Downer, Toll-like receptor signalling as a cannabinoid target in multiple sclerosis, Neuropharmacology, 113 (2017), 618–626. https://doi.org/10.1016/j.neuropharm.2016.04.009 doi: 10.1016/j.neuropharm.2016.04.009
![]() |
[62] |
S. G. Fagan, V. A. Campbell, The influence of cannabinoids on generic traits of neurodegeneration, Br. J. Pharmacol., 171 (2014), 1347–1360. https://doi.org/10.1016/j.neuropharm.2016.04.009 doi: 10.1016/j.neuropharm.2016.04.009
![]() |
[63] |
D. An, S. Peigneur, J. Tytgat, WIN55,212-2, a dual modulator of cannabinoid receptors and G protein-coupled inward rectifier potassium channels, Biomedicines, 9 (2021), 484. https://doi.org/10.3390/biomedicines9050484 doi: 10.3390/biomedicines9050484
![]() |
[64] |
C. J. Wenthur, B. Zhou, K. D. Janda, Vaccine-driven pharmacodynamic dissection and mitigation of fenethylline psychoactivity, Nature, 548 (2017), 476–479. https://doi.org/10.1038/nature23464 doi: 10.1038/nature23464
![]() |
[65] |
I. M. Johnson, H. Prakash, J. Prathiba, R. Raghunathan, R. Malathi, Spectral analysis of naturally occurring methylxanthines (theophylline, theobromine and caffeine) binding with DNA, PLoS One, 7 (2012), e50019. https://doi.org/10.1371/journal.pone.0050019 doi: 10.1371/journal.pone.0050019
![]() |
[66] |
M. Wepler, J. M. Preuss, T. Merz, O. McCook, P. Radermacher, J. P. Tuckermann, et al., Impact of downstream effects of glucocorticoid receptor dysfunction on organ function in critical illness-associated systemic inflammation, Intensive. Care Med. Exp., 8 (2020), 37. https://doi.org/10.1186/s40635-020-00325-z doi: 10.1186/s40635-020-00325-z
![]() |
[67] |
A. E. Coutinho, K. E. Chapman, The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights, Mol. Cell. Endocrinol., 335 (2011), 2–13. https://doi.org/10.1016/j.mce.2010.04.005 doi: 10.1016/j.mce.2010.04.005
![]() |
1. | Rania Saadeh, Laith Hamdi, Ahmad Qazza, 2024, Chapter 18, 978-981-97-4875-4, 259, 10.1007/978-981-97-4876-1_18 | |
2. | Saad Ihsan Butt, Ahmad Khan, Sanja Tipurić-Spužević, New fractal–fractional Simpson estimates for twice differentiable functions with applications, 2024, 51, 23074108, 100205, 10.1016/j.kjs.2024.100205 | |
3. | Rania Saadeh, Motasem Mustafa, Aliaa Burqan, 2024, Chapter 17, 978-981-97-4875-4, 239, 10.1007/978-981-97-4876-1_17 |